← FDA DRUG APPROVALS

FDA ANDA · ANDA065320

ERYTHROMYCIN

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA065320
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-25
LATEST ACTION
2006-07-25
ROUTE
TOPICAL
DOSAGE FORM
SWAB
MARKETING STATUS
Discontinued

Products

ERYTHROMYCINDiscontinued
ERYTHROMYCIN 2% · SWAB · TOPICAL

Approval history

2006-07-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →